About PhRMA
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are laser focused on developing innovative medicines that transform lives and create a healthier world. Together, we are fighting for solutions to ensure patients can access and afford medicines that prevent, treat and cure disease. Over the last decade, PhRMA member companies have invested more than $850 billion in the search for new treatments and cures, and they support nearly five million jobs in the United States.
Connect with PhRMA
For information on how innovative medicines save lives, please visit:
www.PhRMA.org
www.VotersforCures.org
www.AmericasMedicines.com
www.Facebook.com/PhRMA
www.X.com/PhRMA
PhRMA’s Global Access to New Medicines Report analyzes what share of new medicines are available in over 70 countries and how long patients wait to receive them. The Global Access to New Medicines Report includes comprehensive comparisons across countries in the G20, OECD and several geographic regions. Policymakers can enable timely patient access to new medicines by having strong intellectual property rights and enforcement, science-based and globally-harmonized regulatory review, and transparent pricing and reimbursement policies that value innovation.
Global Access to New Medicines Report image
Report
Access to Medicines
Global Access to New Medicines Report
Global Access to New Medicines Report image